Stocks
Innate ImmunotherapeuticsINNT
Congressional Interest in Innate Immunotherapeutics (INNT)
3 members of Congress have disclosed 4 trades in Innate Immunotherapeutics (INNT). The buy/sell breakdown shows 4 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
3
Buys
4
Sells
0
Who in Congress Is Trading INNT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-06-12 | JOHN ABNEY CULBERSON | buy | $1K-$15K |
| 2017-02-03 | K. Michael Conaway | buy | $1K-$15K |
| 2015-01-23 | Tom Price | buy | $1K-$15K |
| 2015-01-08 | Tom Price | buy | $1K-$15K |